-nidine
Drugs that activate alpha-2 adrenergic receptors.
- Drugs ending in -nidine: 14
- Approved somewhere: 9
- With a US drug page: 7
- Stem
- -nidine
- Class
- Drugs that activate alpha-2 adrenergic receptors
- Sub-stems
- -(o)nidine
- Most common targets
- Adrenergic receptor alpha-2 (4), Sodium channel alpha subunit (2), NISCH (2), SLC6A2 (1), Voltage-gated potassium channel (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -nidine or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Bethanidine | Approved | SLC6A2 | Norepinephrine transporter substrate |
| Guanidine | Approved | Voltage-gated potassium channel | Voltage-gated potassium channel blocker |
| Quinidine | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Tizanidine | Approved | Adrenergic receptor alpha-2 | Adrenergic receptor alpha-2 agonist |
| Quinidine polygalacturonate | — | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Rilmenidine | Approved | NISCH | Nischarin agonist |
| Hydroquinidine | Phase 3 | — | — |
| Octenidine | Phase 2 | — | Antiseptic |
| Sulfaguanidine | — | — | — |
| Apraclonidine | Approved | Adrenergic receptor alpha-2 | Adrenergic receptor alpha-2 agonist |
| Brimonidine | Approved | Adrenergic receptor alpha-2 | Adrenergic receptor alpha-2 agonist |
| Clonidine | Approved | Adrenergic receptor alpha-2 | Adrenergic receptor alpha-2 agonist |
| Moxonidine | Approved | NISCH | Nischarin agonist |
| Tolonidine | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO